Review
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Apr 16, 2015; 7(4): 328-335
Published online Apr 16, 2015. doi: 10.4253/wjge.v7.i4.328
Quality monitoring in colonoscopy: Time to act
Mary A Atia, Francisco C Ramirez, Suryakanth R Gurudu
Mary A Atia, Francisco C Ramirez, Suryakanth R Gurudu, Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, Scottsdale, AZ 85259, United States
Author contributions: Atia MA composed majority of the manuscript with in-depth literature review; Ramirez FC edited the manuscript, provided additional references; Gurudu SR helped formulate literature review, final review of the manuscript.
Conflict-of-interest: We have no conflict of interest to disclose.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Suryakanth R Gurudu, MD, Division of Gastroenterology and Hepatology, Mayo Clinic Arizona,1300 E. Shea Boulevard, Scottsdale, AZ 85259, United States. gurudu.suryakanth@mayo.edu
Telephone: +1-480-3016990
Received: August 27, 2014
Peer-review started: August 28, 2014
First decision: December 26, 2014
Revised: January 3, 2015
Accepted: January 18, 2015
Article in press: January 20, 2015
Published online: April 16, 2015
Abstract

Colonoscopy is the gold standard test for colorectal cancer screening. The primary advantage of colonoscopy as opposed to other screening modalities is the ability to provide therapy by removal of precancerous lesions at the time of detection. However, colonoscopy may miss clinically important neoplastic polyps. The value of colonoscopy in reducing incidence of colorectal cancer is dependent on many factors including, the patient, provider, and facility level. A high quality examination includes adequate bowel preparation, optimal colonoscopy technique, meticulous inspection during withdrawal, identification of subtle flat lesions, and complete polypectomy. Considerable variation among institutions and endoscopists has been reported in the literature. In attempt to diminish this disparity, various approaches have been advocated to improve the quality of colonoscopy. The overall impact of these interventions is not yet well defined. Implementing optimal education and training and subsequently analyzing the impact of these endeavors in improvement of quality will be essential to augment the utility of colonoscopy for the prevention of colorectal cancer.

Keywords: Colonoscopy, Quality improvement, Cecal intubation rate, Adenoma detection rate

Core tip: Quality is a measure of actual performance compared to the defined standard as outlined by the medical community. Important quality measures in colonoscopy include informed consent, adequate bowel preparation, cecal intubation, withdrawal time, adenoma detection rate, appropriate screening and surveillance follow-up recommendations, and adverse events. The above quality measures could affect patient outcomes and therefore should be implemented and monitored regularly.